Tos y disnea de seis años de evolución en un adulto joven con melioidosis pulmonar crónica. Reporte de caso

  • Carlos Hernán Rosero Arellano Hospital Universitario de San Vicente Fundación
  • Gustavo Gómez Hospital Universitario de San Vicente Fundación
  • Oscar Iván Gutiérrez Sanjuán Clínica Las Américas
Palabras clave: melioidosis, infecciones por Burkholderia, Burkholderia pseudomallei.

Resumen

La melioidosis es una enfermedad infecciosa causada por una bacteria gram-negativa intracelular Burkholderia pseudomallei. Este microorganismo es un saprofito ambiental en regiones endémicas, algunas de ellas ubicadas probablemente en el territorio nacional y presenta alto riesgo de propagación como epidemia en zonas no endémicas. La melioidosis es una enfermedad clínicamente diversa, la mayoría de las infecciones son asintomáticas; sin embargo, si el paciente es sintomático, se puede clasificar como aguda o crónica según su persistencia. La presentación clínica más común es la afectación pulmonar y al diagnóstico predominan baciloscopias persistentemente negativas. Aquí se presenta un caso de un paciente con tos crónica, expectoración mucopurulenta, sudoración nocturna y disnea.

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Carlos Hernán Rosero Arellano, Hospital Universitario de San Vicente Fundación

Médico internista, Hospital Universitario de San Vicente Fundación. Medellín, Colombia.

Gustavo Gómez, Hospital Universitario de San Vicente Fundación

Médico neumólogo, Hospital Universitario de San Vicente Fundación. Medellín, Colombia.

Oscar Iván Gutiérrez Sanjuán, Clínica Las Américas

Médico general, Clínica Las Américas. Medellín, Colombia.

Referencias bibliográficas

Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005; 18: 383-416.

https://doi.org/10.1128/CMR.18.2.383-416.2005

White NJ. Melioidosis. Lancet 2003; 361: 1715-1722.

https://doi.org/10.1016/S0140-6736(03)13374-0

Dance DA. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop 2000; 74: 159-168.

https://doi.org/10.1016/S0001-706X(99)00066-2

Currie BJ, Fisher DA, Anstey NM, Jacups SP. Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg 2000; 94: 301-304.

https://doi.org/10.1016/S0035-9203(00)90333-X

Dance DA. Melioidosis: the tip of the iceberg? Clin Microbiol Rev 1991; 4: 52-60.

https://doi.org/10.1128/CMR.4.1.52

Rolim DB, Vilar DC, Sousa AQ, Miralles IS, de Oliveira DC, Harnett G, et al. Melioidosis, northeastern Brazil. Emerg Infect Dis 2005; 11: 1458-1460.

https://doi.org/10.3201/eid1109.050493

Montufar F, Ochoa J, Ortega H, Franco L. Melioidosis in Colombia. An Emerging Disease. Chest 2011; 140: 753A.

https://doi.org/10.1378/chest.1119699

Mandell GL, Bennett JE, Dolin R. Mandell, Bennett, & Dolin: Principles and practice of infectious diseases (ed 6th). Philadelphia: Elsevier Churchill Livingstone; 2005.

Stanton AT, Fletcher W. Melioidosis, a new disease of the tropics. Fourth Congress of the Far Eastern Association of Tropical Medicine. Batavia, 1921.

Inglis TJ, Rolim DB, Sousa Ade Q. Melioidosis in the Americas. Am J Trop Med Hyg 2006; 75: 947-954.

https://doi.org/10.4269/ajtmh.2006.75.947

Currie BJ, Fisher DA, Howard DM, Burrow JN, Selvanayagam S, Snelling PL, et al. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 2000; 74: 121-127.

https://doi.org/10.1016/S0001-706X(99)00060-1

Dance DAB. Melioidosis. Rev Med Microbiol 1990; 1: 143-150.

Leelarasamee A, Bovornkitti S. Melioidosis: review and update. Rev Infect Dis 1989; 11: 413-425.

https://doi.org/10.1093/clinids/11.3.413

Green RN, Tuffnell PG. Laboratory acquired melioidosis. Am J Med 1968; 44: 599-605.

https://doi.org/10.1016/0002-9343(68)90060-0

Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, Rajanuwong A, Wuthiekanun V, et al. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 1999; 29: 381-387.

https://doi.org/10.1086/520219

Vadivelu J, Puthucheary SD, Mifsud A, Drasar BS, Dance DA, Pitt TI. Ribotyping and DNA macrorestriction analysis of isolates of Burkholderia pseudomallei from cases of melioidosis in Malaysia. Trans R Soc Trop Med Hyg 1997; 91: 358-360.

https://doi.org/10.1016/S0035-9203(97)90107-3

Chan KW, Jayaratnam FJ, Teo SK. Acute septicaemic melioidosis. A report of three fatal cases. Singapore Med J 1985; 26: 382-385.

Lim MK, Tan EH, Soh CS, Chang TL. Burkholderia pseudomallei infection in the Singapore Armed Forces from 1987 to 1994--an epidemiological review. Ann Acad Med Singapore 1997; 26: 13-17.

Currie BJ, Fisher DA, Howard DM, Burrow JN, Lo D, Selva-Nayagam S, et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 2000; 31: 981-986.

https://doi.org/10.1086/318116

Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, Davis TM, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989; 159: 890-899.

https://doi.org/10.1093/infdis/159.5.890

Warner J, Learoyd D, Pelowa D. Melioidosis in the Western Province of Papua New Guinea. In: Annual Scientific Meeting, Medical Society of Papua New Guinea, Port Moresby. 1998.

Le Hello S, Currie BJ, Godoy D, Spratt BG, Mikulski M, Lacassin F, et al. Melioidosis in New Caledonia. Emerg Infect Dis 2005; 11: 1607-1609.

https://doi.org/10.3201/eid1110.050823

González G, Mantilla WA, Rada R. Neumonía y osteomielitis por Burkholderia pseudomallei, reporte de un caso clínico. Rev Fac Med 2009; 17: 146-149.

Dance DA. Melioidosis as an emerging global problem. Acta Trop 2000; 74: 115-119.

https://doi.org/10.1016/S0001-706X(99)00059-5

Limmathurotsakul D, Chaowagul W, Chierakul W, Stepniewska K, Maharjan B, Wuthiekanun V, et al. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis 2006; 43: 979-986.

https://doi.org/10.1086/507632

Suputtamongkol Y, Chaowagul W, Chetchotisakd P, Lertpatanasuwun N, Intaranongpai S, Ruchutrakool T, et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis 1999; 29: 408-413.

https://doi.org/10.1086/520223

Sookpranee M, Lumbiganon P, Boonma P. Nosocomial contamination of Pseudomonas pseudomallei in the patients at Srinagarind Hospital. In: Melioidosis, Punyagupta S, Sirisanthana T, Stapatayavong B (Eds), Bangkok Medical Publisher, Bangkok 1989.

Leelarasamee A. Melioidosis in Southeast Asia. Acta Trop 2000; 74: 129-132.

https://doi.org/10.1016/S0001-706X(99)00061-3

Singapore Committee on Epidemic Diseases: Melioidosis in Singapore. Epidemiological News Bulletin 1995; 21:69.

Currie BJ. Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions. Eur Respir J 2003; 22: 542-550.

https://doi.org/10.1183/09031936.03.00006203

Osteraas GR, Hardman JM, Bass JW, Wilson C. Neonatal melioidosis. Am J Dis Child 1971; 122: 446-448.

https://doi.org/10.1001/archpedi.1971.02110050116019

Kan SK, Kay RW. Melioidosis presenting as prostatitis--a case report from Sabah. Trans R Soc Trop Med Hyg 1978; 72: 522-524.

https://doi.org/10.1016/0035-9203(78)90175-X

Morse LP, Moller CC, Harvey E, Ward L, Cheng AC, Carson PJ, et al. Prostatic abscess due to Burkholderia pseudomallei: 81 cases from a 19-year prospective melioidosis study. J Urol 2009; 182: 542-547; discussion 547.

https://doi.org/10.1016/j.juro.2009.04.010

Steinmetz I, Stosiek P, Hergenrother D, Bar W. Melioidosis causing a mycotic aneurysm. Lancet 1996; 347: 1564-1565.

https://doi.org/10.1016/S0140-6736(96)90722-9

Woods ML, 2nd, Currie BJ, Howard DM, Tierney A, Watson A, Anstey NM, et al. Neurological melioidosis: seven cases from the Northern Territory of Australia. Clin Infect Dis 1992; 15: 163-169.

https://doi.org/10.1093/clinids/15.1.163

Anunnatsiri S, Chetchotisakd P, Kularbkaew C. Mycotic aneurysm in Northeast Thailand: the importance of Burkholderia pseudomallei as a causative pathogen. Clin Infect Dis 2008; 47: 1436-1439.

https://doi.org/10.1086/592975

Ruff MJ, Lamkin N, Jr., Braun J, Barnwell P. Melioidosis complicated by pericarditis. Chest 1976; 69: 227-229.

https://doi.org/10.1378/chest.69.2.227

Weber DR, Douglass LE, Brundage WG, Stallkamp TC. Acute varieties of melioidosis occurring in U. S. soldiers in Vietnam. Am J Med 1969; 46: 234-244.

https://doi.org/10.1016/0002-9343(69)90008-4

Miralles IS, Maciel Mdo C, Angelo MR, Gondini MM, Frota LH, dos Reis CM, et al. Burkholderia pseudomallei: a case report of a human infection in Ceara, Brazil. Rev Inst Med Trop Sao Paulo 2004; 46: 51-54.

https://doi.org/10.1590/S0036-46652004000100011

Gilligan PH, Lum G, Vandamme P, Whitter S. Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamonas, Delftia, Pandoraea, and Acidovorax. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology (ed 8th). Washington DC: ASM Press; 2003: 729-748.

Jenney AW, Lum G, Fisher DA, Currie BJ. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents 2001; 17: 109-113.

https://doi.org/10.1016/S0924-8579(00)00334-4

Smith MD, Wuthiekanun V, Walsh AL, White NJ. Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies. J Antimicrob Chemother 1994; 33: 145-149.

https://doi.org/10.1093/jac/33.1.145

Toohey M, Lew AE, Desmarchelier PM. Laboratory investigations of Australian isolates of ceftazidime resistant Pseudomonas pseudomallei. Antibiotic Special Interest Group (Australian Society of Microbiology). Newsletter 1994; 2: 1.

Chaowagul W, Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, White NJ. A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin Infect Dis 1999; 29: 375-380.

https://doi.org/10.1086/520218

Cómo citar
1.
Rosero Arellano CH, Gómez G, Gutiérrez Sanjuán OI. Tos y disnea de seis años de evolución en un adulto joven con melioidosis pulmonar crónica. Reporte de caso . Med. Lab. [Internet]. 1 de septiembre de 2013 [citado 22 de enero de 2022];19(9-10):465-72. Disponible en: https://medicinaylaboratorio.com/index.php/myl/article/view/243
Publicado
2013-09-01
Sección
Casos clínicos